---
title: "Xiangyu Medical Co.,Ltd. (688626.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688626.SH.md"
symbol: "688626.SH"
name: "Xiangyu Medical Co.,Ltd."
industry: "Health Care Equipment"
datetime: "2026-05-19T23:16:25.915Z"
locales:
  - [en](https://longbridge.com/en/quote/688626.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688626.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688626.SH.md)
---

# Xiangyu Medical Co.,Ltd. (688626.SH)

## Company Overview

Xiangyu Medical Co.,Ltd engages in the research and development, manufacture, and marketing of rehabilitation and physiotherapy equipment in China. It provides various therapy such as smart occupational, electro, sport, rehab, cold and heat, gait training device, hydrotherapy, air compression, phototherapy, traction table, magnetic, CPM, occupational, shock wave and ultrasound, massage, treatment table, tilt table, therapy, micro and shock wave therapy. The company was incorporated in 2002 and is based in Anyang, China.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | CN Market |
| Website | [www.xyyl.com](https://www.xyyl.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:08.000Z

**Overall: C (0.48)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 40 / 64 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 1.88% |  |
| Net Profit YoY | -7.25% |  |
| P/B Ratio | 4.56 |  |
| Dividend Ratio | 0.39% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 9590832831.39 |  |
| Revenue | 774040276.08 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 3.89% | C |
| Profit Margin | 10.39% | B |
| Gross Margin | 68.20% | A |
| Revenue YoY | 1.88% | C |
| Net Profit YoY | -7.25% | C |
| Total Assets YoY | 8.43% | B |
| Net Assets YoY | 3.21% | C |
| Cash Flow Margin | 239.47% | A |
| OCF YoY | 1.88% | C |
| Turnover | 0.24 | D |
| Gearing Ratio | 37.24% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Xiangyu Medical Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "1.88%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-7.25%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "4.56",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.39%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "9590832831.39",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "774040276.08",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "3.89%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "10.39%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "68.20%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "1.88%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-7.25%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "8.43%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "3.21%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "239.47%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "1.88%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.24",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "37.24%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 124.84 | 45/64 | 132.55 | 111.20 | 86.39 |
| PB | 4.78 | 52/64 | 4.97 | 4.36 | 3.69 |
| PS (TTM) | 12.98 | 55/64 | 13.14 | 11.47 | 9.66 |
| Dividend Yield | 0.37% | 44/64 | 0.50% | 0.42% | 0.36% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | APT (688617.SH) | A | B | B | A | B | A |
| 02 | United Imaging Healthcare (688271.SH) | B | A | C | B | B | B |
| 03 | iRay (688301.SH) | B | A | D | C | A | B |
| 04 | YUYUE MEDICAL (002223.SZ) | B | C | C | A | C | B |
| 05 | Insight Lifetech (688712.SH) | B | A | E | A | A | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-12T16:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 2 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 62.83 |
| Highest Target | 58.00 |
| Lowest Target | 58.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/688626.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/688626.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/688626.SH/news.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**